(40 mg + 0.25 mg)/g, skin solution
Erythromycin+ Tretinoin
Aknemycin Plus is a solution for topical use on the skin. The active substances of the medicine are erythromycin and tretinoin.
Erythromycin is a macrolide antibiotic that acts on Gram-positive and some Gram-negative bacteria, including Propionibacterium acnes, which plays a significant role in the development of acne.
Tretinoin belongs to the group of retinoids, which promotes skin exfoliation, inhibits keratinization of the epidermis, and causes the removal of blackheads.
All forms of acne, including non-inflammatory forms with blackheads and inflammatory forms with pustules, especially in patients with high sebum production.
Before starting to use Aknemycin Plus, you should consult a doctor or pharmacist.
Be careful not to get Aknemycin Plus in your eyes or under your eyelids.
If the medicine comes into contact with your eyes, rinse them thoroughly with plenty of water.
Aknemycin Plus should not be applied to the area around the mouth and nose.
In the initial period of treatment, there may be an exacerbation of acne lesions with an increase in inflammatory reactions - this is a sign that the medicine has started to work, and these symptoms are usually transient. This is not a reason to discontinue treatment, but your doctor may reduce the frequency of application.
The medicine should always be applied using the applicator provided. If, despite using the applicator, the medicine comes into contact with your fingers, wash your hands thoroughly.
During therapy with Aknemycin Plus, the skin may become more sensitive (photosensitive) to ultraviolet radiation (UV) (sunlight, quartz lamps, or sunbeds).
Skin irritation that occurs during treatment (see section 4) may worsen due to UV radiation, X-ray radiation, or bathing in saltwater or chlorinated water. This applies especially to people who are exposed to sunlight for a long time and to patients who are particularly sensitive to sunlight. During treatment with Aknemycin Plus, you should avoid direct exposure to sunlight or UV radiation from other sources (i.e., from sunlamps and sunbeds).
Before using Aknemycin Plus, any sunburn should be healed.
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Avoid using other skin medicines at the same time, due to the risk of exacerbating skin irritation.
Skin irritation that occurs during treatment may worsen due to UV radiation (sunlight, quartz lamps, sunbeds), X-ray radiation, or bathing in saltwater or chlorinated water.
Before using any medicine, consult your doctor.
Aknemycin Plus should not be used during pregnancy or when planning to become pregnant. For more information, consult your doctor.
Special caution should be exercised when the doctor recommends using the medicine during breastfeeding.
To avoid direct contact between the medicine and the baby's skin, Aknemycin Plus should not be applied to the breast during breastfeeding.
The medicine has no effect on the ability to drive or use machines.
This medicine contains 752 mg of alcohol (ethanol) per ml of solution, which may cause a burning sensation on damaged skin.
Due to the alcohol content, the medicine is flammable. Keep it away from fire and do not use it near an open flame, lit cigarette, or certain devices (e.g., hair dryers).
This medicine should always be used as directed by your doctor. If you have any doubts, consult your doctor or pharmacist.
The medicine is intended for topical use on the skin.
Apply the medicine to the affected skin once or twice a day, after first cleaning the skin.
Aknemycin Plus should be applied directly to the skin using the applicator provided.
The applicator prevents contamination of the solution from the skin.
Treatment should not exceed 12 weeks.
No data available.
If you use more of the medicine than recommended or accidentally swallow it, contact your doctor.
Do not use a double dose to make up for a missed dose.
If you have any further doubts about using this medicine, consult your doctor or pharmacist.
Like all medicines, Aknemycin Plus can cause side effects, although not everybody gets them.
Rarely (less than 1 in 1000 treated patients), the medicine may cause skin discoloration, skin irritation in the form of redness, burning, dryness, and flaking.
Very rarely (less than 1 in 10,000 treated patients), the above side effects may be symptoms of an allergic reaction (allergic contact dermatitis).
In the initial period of treatment, there may be an exacerbation of acne lesions with an increase in inflammatory reactions.
If the patient experiences a severe skin reaction: red, flaking rash with nodules under the skin and blisters (pustular eruption), they should contact their doctor immediately. The frequency of these side effects is unknown (cannot be determined from available data).
If you experience any side effects, including any side effects not listed in this leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store at a temperature below 25°C.
The medicine is flammable. For more information, see section 2.
Shelf life after first opening the bottle: 6 months.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substances of the medicine are erythromycin and tretinoin.
1 g of solution contains 40 mg of erythromycin and 0.25 mg of tretinoin.
The other ingredients (excipients) of the medicine are: ethanol 95%, glycerol 85%, copolyvidone.
Aknemycin Plus is a solution for the skin.
The medicine is available in a 25 ml solution for the skin in a brown glass bottle with an applicator, sealed with a white cap, and packaged in a cardboard box.
For more detailed information, consult the marketing authorization holder or parallel importer.
Almirall Hermal GmbH
Scholtzstrasse 3
D-21465 Reinbek
Germany
Almirall Hermal GmbH
Scholtzstrasse 1, 3, and 6
D-21465 Reinbek
Schleswig-Holstein
Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in the Czech Republic, the country of export:46/268/02-C
Parallel import authorization number:893/12
Date of approval of the leaflet: 20.09.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.